| 产品描述: | (R)-Vanzacaftor ((R)-VX-121) is a regulator of cystic fibrosis transmembrane conduction regulator (CFTR). |
| 参考文献: |
1. Jeremy J. Clemens, et al. Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators. US20190248809A1.2019-08-15. |
| 保存条件: |
-80°C 6个月; -20°C 1个月,氮气保存 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.619 ml |
8.094 ml |
16.188 ml |
| 5 mM |
0.324 ml |
1.619 ml |
3.238 ml |
| 10 mM |
0.162 ml |
0.809 ml |
1.619 ml |
| 50 mM |
0.032 ml |
0.162 ml |
0.324 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |